Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04410796
Title Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center

lung non-small cell carcinoma


Carboplatin + Osimertinib + Pemetrexed Disodium


Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.